2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow AZD-8871: new trials by email Literature Review of AZD-8871 trials Research Report on AZD-8871
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Single Inhalation Dose Study to Assess Efficacy, Pharmacokinetics (PK), Safety and Tolerability of AZD8871 in Patients With Long-term Lung Diseases. AZD8871, Anoro® Ellipta® - Chronic Obstructive Pulmonary Disease | Phase 2 | Completed | AstraZeneca | 73 | 2018-10-10 | 2020-12-17 |
| Efficacy, Pharmacokinetics (PK), Safety and Tolerability Study of Inhaled AZD8871 AZD8871 100 µg, AZD8871 600 µg, Placebo - Chronic Obstructive Pulmonary Disease COPD | Phase 2 | Completed | AstraZeneca | 42 | 2016-12-15 | 2019-06-18 |
Pulmonary Disease, Chronic Obstructive (2) · Emphysema (1)
AstraZeneca (2)
Germany (2) · United Kingdom (2)
Dave Singh, Prof (1) · Rainard Fuhr, Dr (1)